Pre-Conference Day - Tuesday October 1, 2024

Workshop A | 9.00 – 11.30

Pioneering the Next Generation of Connected Devices & Digital Health to Transform Patient Adherence & Experience

  • Heydy Andolz Advisor Engineer, Eli Lilly and Company
  • Li-Chun Tsou Director, Global Device Engineering & Technologies, Global MSAT - Drug Delivery & Aseptic Technology, GSK

Synopsis

In recent years, off the back of the COVID-19 pandemic, at-home patient care, and connectivity has become the norm, and this applies to self-administration and integration of connectivity in injectable devices. Now more than ever, patient centricityand adapting to these needs are ever-important. Delve int o the transformative potential of connected devices in a world beyond diabetes management.

Join us in this interactive workshop to explore:

  • Outlining the advantages of the use of real-time monitoring, feedback and intervention to maximize patient outcomes
  • Exploring the competitive landscape for sterile injectable devices
  • Understanding the strength and opportunity for connected devices
  • Delving into the future outlook of drug delivery devices connected solutions to promote patient adherence and meet user needs
  • Understanding human factors associated with evaluating a connected combination product
  • Assessing human behavior when it comes to adding connectivity to the user interface and user experience

Workshop B | 12.30 – 3.00

Advancing Patient Centric Drug Products in High Concentration Formulations

  • Hiten Gutka Senior Principal Scientist, Bristol Myers Squibb

Synopsis

With the drive for higher volume injectables, patient comfort and compliance must be addressed by minimizing injection pain and volume while maintaining dosage accuracy. Join this session to foster advancement of patient- centric drug products in high-concentration formulations for injectable combinations, enhancing therapeutic outcomes.

Join us as we delve into:

  • Exploring considerations with formulation composition, dosage form design and primary packaging considerations
  • Extrapolating learnings from commercial drug products and applying them for future perspectives
  • Understanding the technical challenges such as stability, viscosity and volume limitations and exploring best options